The global market for Artificial Tissue Chips was valued at US$ 171 million in the year 2024 and is projected to reach a revised size of US$ 816 million by 2031, growing at a CAGR of 25.4% during the forecast period.
Artificial Tissue Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and Organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Tissue Chips, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Tissue Chips.
The Artificial Tissue Chips market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Tissue Chips market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Tissue Chips manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
by Type
Brain-on-a-Chip
Liver-on-a-Chip
Kidney-on-a-Chip
Lung-on-a-Chip
Heart-on-a-Chip
Intestine-on-a-Chip
Vessel-on-a-Chip
Others
by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Production by Region
North America
Europe
China
Japan
South Korea
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Tissue Chips manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Artificial Tissue Chips by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Artificial Tissue Chips in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Artificial Tissue Chips 麻豆原创 Overview
1.1 Product Definition
1.2 Artificial Tissue Chips by Type
1.2.1 Global Artificial Tissue Chips 麻豆原创 Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Brain-on-a-Chip
1.2.3 Liver-on-a-Chip
1.2.4 Kidney-on-a-Chip
1.2.5 Lung-on-a-Chip
1.2.6 Heart-on-a-Chip
1.2.7 Intestine-on-a-Chip
1.2.8 Vessel-on-a-Chip
1.2.9 Others
1.3 Artificial Tissue Chips by Application
1.3.1 Global Artificial Tissue Chips 麻豆原创 Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Artificial Tissue Chips Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Artificial Tissue Chips Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Artificial Tissue Chips Production Estimates and Forecasts (2020-2031)
1.4.4 Global Artificial Tissue Chips 麻豆原创 Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Artificial Tissue Chips Production 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Artificial Tissue Chips Production Value 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Key Players of Artificial Tissue Chips, Industry Ranking, 2023 VS 2024
2.4 Global Artificial Tissue Chips 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Artificial Tissue Chips Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Artificial Tissue Chips, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Artificial Tissue Chips, Product Offered and Application
2.8 Global Key Manufacturers of Artificial Tissue Chips, Date of Enter into This Industry
2.9 Artificial Tissue Chips 麻豆原创 Competitive Situation and Trends
2.9.1 Artificial Tissue Chips 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Artificial Tissue Chips Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Artificial Tissue Chips Production by Region
3.1 Global Artificial Tissue Chips Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Artificial Tissue Chips Production Value by Region (2020-2031)
3.2.1 Global Artificial Tissue Chips Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Artificial Tissue Chips by Region (2026-2031)
3.3 Global Artificial Tissue Chips Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Artificial Tissue Chips Production Volume by Region (2020-2031)
3.4.1 Global Artificial Tissue Chips Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Artificial Tissue Chips by Region (2026-2031)
3.5 Global Artificial Tissue Chips 麻豆原创 Price Analysis by Region (2020-2025)
3.6 Global Artificial Tissue Chips Production and Value, Year-over-Year Growth
3.6.1 North America Artificial Tissue Chips Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Artificial Tissue Chips Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Artificial Tissue Chips Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Artificial Tissue Chips Production Value Estimates and Forecasts (2020-2031)
3.6.5 South Korea Artificial Tissue Chips Production Value Estimates and Forecasts (2020-2031)
4 Artificial Tissue Chips Consumption by Region
4.1 Global Artificial Tissue Chips Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Artificial Tissue Chips Consumption by Region (2020-2031)
4.2.1 Global Artificial Tissue Chips Consumption by Region (2020-2025)
4.2.2 Global Artificial Tissue Chips Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Artificial Tissue Chips Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Artificial Tissue Chips Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Artificial Tissue Chips Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Artificial Tissue Chips Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific Artificial Tissue Chips Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Artificial Tissue Chips Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Artificial Tissue Chips Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Artificial Tissue Chips Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Israel
5 Segment by Type
5.1 Global Artificial Tissue Chips Production by Type (2020-2031)
5.1.1 Global Artificial Tissue Chips Production by Type (2020-2025)
5.1.2 Global Artificial Tissue Chips Production by Type (2026-2031)
5.1.3 Global Artificial Tissue Chips Production 麻豆原创 Share by Type (2020-2031)
5.2 Global Artificial Tissue Chips Production Value by Type (2020-2031)
5.2.1 Global Artificial Tissue Chips Production Value by Type (2020-2025)
5.2.2 Global Artificial Tissue Chips Production Value by Type (2026-2031)
5.2.3 Global Artificial Tissue Chips Production Value 麻豆原创 Share by Type (2020-2031)
5.3 Global Artificial Tissue Chips Price by Type (2020-2031)
6 Segment by Application
6.1 Global Artificial Tissue Chips Production by Application (2020-2031)
6.1.1 Global Artificial Tissue Chips Production by Application (2020-2025)
6.1.2 Global Artificial Tissue Chips Production by Application (2026-2031)
6.1.3 Global Artificial Tissue Chips Production 麻豆原创 Share by Application (2020-2031)
6.2 Global Artificial Tissue Chips Production Value by Application (2020-2031)
6.2.1 Global Artificial Tissue Chips Production Value by Application (2020-2025)
6.2.2 Global Artificial Tissue Chips Production Value by Application (2026-2031)
6.2.3 Global Artificial Tissue Chips Production Value 麻豆原创 Share by Application (2020-2031)
6.3 Global Artificial Tissue Chips Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Emulate
7.1.1 Emulate Artificial Tissue Chips Company Information
7.1.2 Emulate Artificial Tissue Chips Product Portfolio
7.1.3 Emulate Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Emulate Main Business and 麻豆原创s Served
7.1.5 Emulate Recent Developments/Updates
7.2 TissUse
7.2.1 TissUse Artificial Tissue Chips Company Information
7.2.2 TissUse Artificial Tissue Chips Product Portfolio
7.2.3 TissUse Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.2.4 TissUse Main Business and 麻豆原创s Served
7.2.5 TissUse Recent Developments/Updates
7.3 Hesperos
7.3.1 Hesperos Artificial Tissue Chips Company Information
7.3.2 Hesperos Artificial Tissue Chips Product Portfolio
7.3.3 Hesperos Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hesperos Main Business and 麻豆原创s Served
7.3.5 Hesperos Recent Developments/Updates
7.4 CN Bio Innovations
7.4.1 CN Bio Innovations Artificial Tissue Chips Company Information
7.4.2 CN Bio Innovations Artificial Tissue Chips Product Portfolio
7.4.3 CN Bio Innovations Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.4.4 CN Bio Innovations Main Business and 麻豆原创s Served
7.4.5 CN Bio Innovations Recent Developments/Updates
7.5 Tara Biosystems
7.5.1 Tara Biosystems Artificial Tissue Chips Company Information
7.5.2 Tara Biosystems Artificial Tissue Chips Product Portfolio
7.5.3 Tara Biosystems Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Tara Biosystems Main Business and 麻豆原创s Served
7.5.5 Tara Biosystems Recent Developments/Updates
7.6 Draper Laboratory
7.6.1 Draper Laboratory Artificial Tissue Chips Company Information
7.6.2 Draper Laboratory Artificial Tissue Chips Product Portfolio
7.6.3 Draper Laboratory Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Draper Laboratory Main Business and 麻豆原创s Served
7.6.5 Draper Laboratory Recent Developments/Updates
7.7 Mimetas
7.7.1 Mimetas Artificial Tissue Chips Company Information
7.7.2 Mimetas Artificial Tissue Chips Product Portfolio
7.7.3 Mimetas Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Mimetas Main Business and 麻豆原创s Served
7.7.5 Mimetas Recent Developments/Updates
7.8 Nortis
7.8.1 Nortis Artificial Tissue Chips Company Information
7.8.2 Nortis Artificial Tissue Chips Product Portfolio
7.8.3 Nortis Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Nortis Main Business and 麻豆原创s Served
7.8.5 Nortis Recent Developments/Updates
7.9 Micronit Microtechnologies B.V.
7.9.1 Micronit Microtechnologies B.V. Artificial Tissue Chips Company Information
7.9.2 Micronit Microtechnologies B.V. Artificial Tissue Chips Product Portfolio
7.9.3 Micronit Microtechnologies B.V. Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Micronit Microtechnologies B.V. Main Business and 麻豆原创s Served
7.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
7.10 Kirkstall
7.10.1 Kirkstall Artificial Tissue Chips Company Information
7.10.2 Kirkstall Artificial Tissue Chips Product Portfolio
7.10.3 Kirkstall Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Kirkstall Main Business and 麻豆原创s Served
7.10.5 Kirkstall Recent Developments/Updates
7.11 Cherry Biotech SAS
7.11.1 Cherry Biotech SAS Artificial Tissue Chips Company Information
7.11.2 Cherry Biotech SAS Artificial Tissue Chips Product Portfolio
7.11.3 Cherry Biotech SAS Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Cherry Biotech SAS Main Business and 麻豆原创s Served
7.11.5 Cherry Biotech SAS Recent Developments/Updates
7.12 Else Kooi Laboratory
7.12.1 Else Kooi Laboratory Artificial Tissue Chips Company Information
7.12.2 Else Kooi Laboratory Artificial Tissue Chips Product Portfolio
7.12.3 Else Kooi Laboratory Artificial Tissue Chips Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Else Kooi Laboratory Main Business and 麻豆原创s Served
7.12.5 Else Kooi Laboratory Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Artificial Tissue Chips Industry Chain Analysis
8.2 Artificial Tissue Chips Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Artificial Tissue Chips Production Mode & Process Analysis
8.4 Artificial Tissue Chips Sales and 麻豆原创ing
8.4.1 Artificial Tissue Chips Sales Channels
8.4.2 Artificial Tissue Chips Distributors
8.5 Artificial Tissue Chips Customer Analysis
9 Artificial Tissue Chips 麻豆原创 Dynamics
9.1 Artificial Tissue Chips Industry Trends
9.2 Artificial Tissue Chips 麻豆原创 Drivers
9.3 Artificial Tissue Chips 麻豆原创 Challenges
9.4 Artificial Tissue Chips 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
听
听
*If Applicable.
